{"id":31563,"date":"2025-08-01T07:00:22","date_gmt":"2025-08-01T11:00:22","guid":{"rendered":"https:\/\/www.ncqa.org\/?page_id=31563"},"modified":"2026-01-30T07:27:21","modified_gmt":"2026-01-30T12:27:21","slug":"kidney-health-evaluation-for-patients-with-diabetes-ked","status":"publish","type":"page","link":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/","title":{"rendered":"Kidney Health Evaluation for Patients With Diabetes (KED)"},"content":{"rendered":"<p><span class=\"TextRun SCXW82286778 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW82286778 BCX0\">The percentage of persons 18\u201385 years of age with diabetes (type 1 or type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW82286778 BCX0\">uACR<\/span><span class=\"NormalTextRun SCXW82286778 BCX0\">), during the measurement period.<\/span><\/span><span class=\"EOP SCXW82286778 BCX0\" data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h2>Why it Matters<\/h2>\n<p><span data-contrast=\"none\">The American Diabetes Association recommends that kidney function be assessed in people with type 1 diabetes with duration of \u22655 years and in all people with type 2 diabetes regardless of treatment .<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">The eGFR test evaluates kidney function; the uACR test evaluates kidney damage. Together they form a comprehensive kidney health evaluation that is essential for both primary detection and ongoing monitoring of chronic kidney disease (CKD) prevention and treatment. The measure aligns with guidelines from the American Diabetes Association that recommend at least annual urinary albumin and eGFR evaluation <sup>(1)<\/sup>.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">To evaluate the risk of kidney disease progression and kidney failure, clinical practice guidelines for CKD specify use of quantitative values of both eGFR and uACR. Combining these quantitative results enables accurate classification of a patient\u2019s risk and tailoring of optimal treatment and care strategies. Guidelines recommend that screening done using a semi-quantitative uACR test at home or point-of-care be confirmed with a quantitative uACR test performed by a certified laboratory.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Despite guideline recommendations, fewer than 50% of adults with diabetes receive annual kidney health evaluation <sup>(1)<\/sup>. The leading cause of kidney disease is diabetes <sup>(2)<\/sup>. Diabetes places adults at a significant risk for developing CKD due to vascular abnormalities that cause damage to kidneys <sup>(3)<\/sup>. Diabetic kidney disease is one of the most common adverse outcomes of diabetes, affecting 20%\u201340% of patients with diabetes. CDC simulation studies showed that uACR screening for early detection of CKD was cost-effective in patients with diabetes, at $50 thousand per quality-adjusted life-year.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Detection of CKD and monitoring that guides prevention and treatment is an important aspect of diabetes management. Undiagnosed CKD can increase chances of related health problems, such as early death, heart disease, stroke, kidney failure and end-stage renal disease (ESRD). If a person is aware of their CKD, they can lower their risk for related health problems and kidney failure <sup>(4)<\/sup>. Regular kidney health evaluations among adults with diabetes are crucial for guiding early diagnosis and treatment that can prevent or delay progression of CKD.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">*This measure was developed by NCQA with input from the National Kidney Foundation.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h2><span data-teams=\"true\">Historical Results \u2013 National Averages<\/span><\/h2>\n","protected":false},"excerpt":{"rendered":"<p>The percentage of persons 18\u201385 years of age with diabetes (type 1 or type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement period.\u00a0 Why it Matters The American Diabetes Association recommends that kidney function be assessed in people with [&hellip;]<\/p>\n","protected":false},"author":45,"featured_media":0,"parent":733,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page.php","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-31563","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kidney Health Evaluation for Patients With Diabetes (KED) - NCQA<\/title>\n<meta name=\"description\" content=\"The percentage of persons 18\u201385 years of age with diabetes (type 1 or type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement period.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kidney Health Evaluation for Patients With Diabetes (KED) - NCQA\" \/>\n<meta property=\"og:description\" content=\"The percentage of persons 18\u201385 years of age with diabetes (type 1 or type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement period.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/\" \/>\n<meta property=\"og:site_name\" content=\"NCQA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/NCQA.org\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-30T12:27:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ncqa.org\/wp-content\/uploads\/2021\/04\/NCQA_cmyk_tag.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@NCQA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/\",\"url\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/\",\"name\":\"Kidney Health Evaluation for Patients With Diabetes (KED) - NCQA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ncqa.org\/#website\"},\"datePublished\":\"2025-08-01T11:00:22+00:00\",\"dateModified\":\"2026-01-30T12:27:21+00:00\",\"description\":\"The percentage of persons 18\u201385 years of age with diabetes (type 1 or type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement period.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ncqa.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Report Cards\",\"item\":\"https:\/\/www.ncqa.org\/report-cards\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Health Plans\",\"item\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"State of Health Care Quality Report\",\"item\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Kidney Health Evaluation for Patients With Diabetes (KED)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ncqa.org\/#website\",\"url\":\"https:\/\/www.ncqa.org\/\",\"name\":\"NCQA\",\"description\":\"Measuring quality. Improving health care.\",\"publisher\":{\"@id\":\"https:\/\/www.ncqa.org\/#organization\"},\"alternateName\":\"National Committee for Quality Assurance\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ncqa.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ncqa.org\/#organization\",\"name\":\"NCQA\",\"alternateName\":\"National Committee for Quality Assurance\",\"url\":\"https:\/\/www.ncqa.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg\",\"contentUrl\":\"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg\",\"width\":876,\"height\":673,\"caption\":\"NCQA\"},\"image\":{\"@id\":\"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/NCQA.org\",\"https:\/\/x.com\/NCQA\",\"https:\/\/www.instagram.com\/ncqa_dc\/\",\"https:\/\/www.youtube.com\/@NcqaOrg\",\"https:\/\/www.linkedin.com\/company\/ncqa\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kidney Health Evaluation for Patients With Diabetes (KED) - NCQA","description":"The percentage of persons 18\u201385 years of age with diabetes (type 1 or type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement period.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/","og_locale":"en_US","og_type":"article","og_title":"Kidney Health Evaluation for Patients With Diabetes (KED) - NCQA","og_description":"The percentage of persons 18\u201385 years of age with diabetes (type 1 or type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement period.\u00a0","og_url":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/","og_site_name":"NCQA","article_publisher":"https:\/\/www.facebook.com\/NCQA.org","article_modified_time":"2026-01-30T12:27:21+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.ncqa.org\/wp-content\/uploads\/2021\/04\/NCQA_cmyk_tag.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@NCQA","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/","url":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/","name":"Kidney Health Evaluation for Patients With Diabetes (KED) - NCQA","isPartOf":{"@id":"https:\/\/www.ncqa.org\/#website"},"datePublished":"2025-08-01T11:00:22+00:00","dateModified":"2026-01-30T12:27:21+00:00","description":"The percentage of persons 18\u201385 years of age with diabetes (type 1 or type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement period.\u00a0","breadcrumb":{"@id":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/kidney-health-evaluation-for-patients-with-diabetes-ked\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ncqa.org\/"},{"@type":"ListItem","position":2,"name":"Report Cards","item":"https:\/\/www.ncqa.org\/report-cards\/"},{"@type":"ListItem","position":3,"name":"Health Plans","item":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/"},{"@type":"ListItem","position":4,"name":"State of Health Care Quality Report","item":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/"},{"@type":"ListItem","position":5,"name":"Kidney Health Evaluation for Patients With Diabetes (KED)"}]},{"@type":"WebSite","@id":"https:\/\/www.ncqa.org\/#website","url":"https:\/\/www.ncqa.org\/","name":"NCQA","description":"Measuring quality. Improving health care.","publisher":{"@id":"https:\/\/www.ncqa.org\/#organization"},"alternateName":"National Committee for Quality Assurance","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ncqa.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ncqa.org\/#organization","name":"NCQA","alternateName":"National Committee for Quality Assurance","url":"https:\/\/www.ncqa.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg","contentUrl":"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg","width":876,"height":673,"caption":"NCQA"},"image":{"@id":"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/NCQA.org","https:\/\/x.com\/NCQA","https:\/\/www.instagram.com\/ncqa_dc\/","https:\/\/www.youtube.com\/@NcqaOrg","https:\/\/www.linkedin.com\/company\/ncqa\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/31563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/comments?post=31563"}],"version-history":[{"count":1,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/31563\/revisions"}],"predecessor-version":[{"id":49478,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/31563\/revisions\/49478"}],"up":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/733"}],"wp:attachment":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/media?parent=31563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}